|
|
Title: Fast dissolving orally
consumable films
United States Patent: 7,407,669
Issued: August 5, 2008
Inventors: Leung; Sau-Hung
Spence (Parsippany, NJ), Leone; Robert S. (Fanwood, NJ), Kumar; Lori D.
(Skillman, NJ), Kulkarni; Neema (Randolph, NJ), Sorg; Albert F. (Columbia,
NJ)
Assignee: McNeil-PPC, Inc.
(New Brunswick, NJ)
Appl. No.: 10/684,778
Filed: October 14, 2003
|
|
|
Pharm Bus Intell
& Healthcare Studies
|
Abstract
Physiologically acceptable films,
including edible films, are disclosed. The films include a water soluble
film-forming polymer such as pullulan. Edible films are disclosed that
include pullulan and antimicrobially effective amounts of the essential
oils thymol, methyl salicylate, eucalyptol and menthol. The edible films
are effective at killing the plaque-producing germs that cause dental
plaque, gingivitis and bad breath. The film can also contain
pharmaceutically active agents. Methods for producing the films are also
disclosed.
Description of the
Invention
SUMMARY OF THE INVENTION
The invention provides a physiologically acceptable film, which is
particularly well adapted to adhere to and rapidly dissolve in the mouth of
a consumer. In a first embodiment of the invention, the film delivers at
least one oral care agent, such as antimicrobial agents and salivary
stimulants. The antimicrobial agents are effective against germs that cause
halitosis, dental plaque, and gingivitis. The salivary stimulants are
effective against the condition known as xerostomia or dry mouth.
Additionally, the oral care films are a breath freshener effective against
oral malodor. The film former used to make the films according to the
present invention entraps the oral care agents in the oral cavity to provide
extended efficacy.
In a second embodiment of the invention, the rapidly dissolvable film acts
as a vehicle for administering a pharmaceutically active agent orally,
through a mucous membrane or an open wound of a patient.
The invention is also directed to a method for producing a supple,
non-self-adhering film especially suitable for oral delivery. The method
comprises mixing a film forming agent and at least one stabilizing agent to
provide a film-forming mixture; dissolving water-soluble ingredients in
water to provide an aqueous solution; combining the film-forming mixture and
the aqueous solution to provide a hydrated polymer gel; mixing oils to form
an oil mixture; adding the oil mixture to the hydrated polymer gel and
mixing to provide a uniform emulsified gel; casting the uniform gel on a
substrate; and drying the cast gel to provide a film.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
Description of Oral Care Film Compositions
The first embodiment of the invention is a physiologically acceptable film
that is particularly well adapted to adhere to and dissolve in a mouth of a
consumer to deliver an antimicrobial agent that kills germs that cause
halitosis, dental plaque and gingivitis. Thus, the film can be an effective
tool in the prevention and treatment of halitosis, dental plaque
accumulation, dental tartar accumulation and gingivitis. This film
preferably comprises pullulan, thymol, methyl salicylate, eucalyptol and
menthol.
LISTERINE.RTM. brand mouthwash is, perhaps, the most well-known example of
an antiseptic oral composition that has proven effective in killing microbes
in the oral cavity that are responsible for plaque, gingivitis and bad
breath. LISTERINE.RTM. brand mouthwash achieves its antimicrobial effect
through a combination of essential oils that penetrate and kill the
microorganisms. These essential oils include precisely balanced amounts of
thymol, methyl salicylate, menthol and eucalyptol (hereinafter "the
essential oils") in a hydro alcoholic solution. Many bad breath bacteria
live in pits or fissure on the surface of the tongue. Listerine.RTM.
Antiseptic mouthwash reduces bad breath because of high concentrations of
antimicrobial agents in a liquid medium that can easily penetrate into these
pits and fissures. This would not be possible with a solid dosage form
containing low amounts of these antimicrobial ingredients. However, the
preferred consumable film of the invention captures a significant portion of
the hygienic benefits and the consumer appeal of LISTERINE.RTM. brand
mouthwash, in a more portable and unobtrusively consumed form.
It was a significant challenge to maintain the essential oil interaction and
relatively high oil content of LISTERINE.RTM. brand mouthwash in a film.
However, the inventors have overcome this challenge in providing the film of
the invention.
A further aspect of this invention is that while the amounts of
LISTERINE.RTM. essential oils are relatively high for incorporation in a
film, the film according to the present invention still delivers a lower
total amount of essential oils per unit dose when compared to that of
LISTERINE.RTM. mouthwash. Yet the film suprisingly provides antimicrobial
efficacy in the oral cavity. The inventors theorize that the preferred film
forming ingredient, pullulan, forms a thin layer on the oral surfaces
entrapping the small amount of essential oils which are capable of
penetrating into the pits and fissures of the oral cavity to provide
sustained antimicrobial efficacy.
Although the inventors are presently unaware of any other breath-freshening
consumable film that provides antimicrobial efficacy, they are aware of a
consumable film disclosed in JP 5-236885, which is said to possess
breath-freshening activity, but is not described as possessing any
ingredients having significant antimicrobial activity. Moreover, JP 5-236885
teaches that its film should contain flavor and extract in amounts of 5 to 7
wt %, with the flavor being added as an oil (the essential oils are not
disclosed), whereas the film of the invention preferably has an oil content
of at least about 10 wt %, more preferably about 15 wt % to about 30 wt %,
most preferably about 15 wt % to about 25 wt %. Except as otherwise noted in
the examples, the amounts of oils and other ingredients in the film are wt %
after the film formulation has been dried to create the film.
The amounts of the specific essential oils used in the film compositions can
vary as long as they are in amounts sufficient to provide antimicrobial
efficacy. Generally the amount of thymol, methyl salicylate and eucalyptol
is from about 0.01 to about 4 wt % of the film composition, preferably about
0.50 to about 3.0 wt % and even more preferably from about 0.70 to about 2.0
wt % of the film. Menthol can be added from about 0.01 to about 15 wt % of
the composition, preferably about 2.0 to about 10 wt % and even more
preferably from about 3 to about 9 wt % of the film. The amounts added can
be readily determined to those skilled in the art and can exceed these
amounts as long as the total oil content does not create sticking or other
processing problems. In certain embodiments, the essential oils are combined
in amounts synergistically effective to kill the plaque-producing germs that
cause dental plaque, gingivitis and bad breath.
A major difficulty in formulating a film having such a relatively high oil
content is that simply increasing the amount of oil in the film without
determining the precise proportions of the many other ingredients typically
results in a film that is too moist and therefore difficult to handle or
process. The inventors have discovered how to provide a high oil content
film that is moist enough so that it is not brittle, but is not so moist
that it feels undesirably slimy or significantly adheres to adjacent films.
Thus, a non-self-adhering film according to the invention can be stored in
contact with another such film (e.g., in a stack), or can be wound about
itself (e.g., around a spool), without having to place a non-stick agent
(e.g., a plastic film, paper or other support) between adjacent portions of
film.
The film-forming agent used in the films according to the present invention
can be selected from the group consisting of pullulan, hydroxypropylmethyl
cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl
pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate,
polyethylene glycol, xanthan gum, tragacanth gum, guar gum, acacia gum,
arabic gum, polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl
polymer, amylose, high amylose starch, hydroxypropylated high amylose
starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen,
gelatin, zein, gluten, soy protein isolate, whey protein isolate, casein and
mixtures thereof. A preferred film former is pullulan, in amounts ranging
from about 0.01 to about 99 wt %, preferably about 30 to about 80 wt %, more
preferably from about 45 to about 70 wt % of the film and even more
preferably from about 60 to about 65 wt % of the film.
The film of the invention preferably comprises pullulan as a film-forming
agent and the essential oils as antimicrobial/flavoring agents, and can
further comprise water, additional antimicrobial agents, additional
film-forming agents, plasticizing agents, additional flavoring agents,
sulfur precipitating agents, saliva stimulating agents, cooling agents,
surfactants, stabilizing agents, emulsifying agents, thickening agents,
binding agents, coloring agents, sweeteners, fragrances, and the like.
Due to the relatively high oil content in the oral care film, it is
preferable to avoid substantial amounts of humectant in the film (and more
preferable to have no humectant in the film), so as to avoid producing an
overly moist, self-adhering film. In particular, it is preferred to
formulate the film with a plasticizing agent other than glycerin, which is
also a humectant, and with a sweetener other than sorbitol, which is a mild
humectant.
Sulfur precipitating agents that reduce oral malodor can also be added to
the oral care films according to the present invention. These agents bind
with, and inactivate, the volatile sulfur compounds that cause a large
percentage of oral malodor. Sulfur precipitating agents useful in the
present invention include metal salts such as copper salts and zinc salts.
Preferred salts include copper gluconate, zinc citrate and zinc gluconate.
The amount of sulfur precipitating agent is from about 0.01 to about 2 wt %,
preferably about 0.15 wt % to about 1.5 wt %, even more preferably about
0.25 wt % to about 1.0 wt % of the film.
Saliva stimulating agents can also be added to the oral care films according
to the present invention. Useful saliva stimulating agents are those
disclosed in U.S. Pat. No. 4,820,506, which is incorporated by reference
herein in its entirety. Saliva stimulating agents include food acids such as
citric, lactic, malic, succinic, ascorbic, adipic, fumaric and tartaric
acids. Preferred food acids are citric, malic and ascorbic acids. The amount
of saliva stimulating agents in the film is from about 0.01 to about 12 wt
%, preferably about 1 wt % to about 10 wt %, even more preferably about 2.5
wt % to about 6 wt %.
Preferred plasticizing agents include triacetin in amounts ranging from
about 0 to about 20 wt %, preferably about 0 to about 2 wt %. Other suitable
plasticizing agents include monoacetin and diacetin.
Preferred cooling agents include monomenthyl succinate, in amounts ranging
from about 0.001 to about 2.0 wt %, preferably about 0.2 to about 0.4 wt %.
A monomenthyl succinate containing cooling agent is available from Mane,
Inc. Other suitable cooling agents include WS3, WS23, Ultracool II and the
like.
Preferred surfactants include mono and diglycerides of fatty acids and
polyoxyethylene sorbitol esters, such as, Atmos 300 and Polysorbate 80. The
surfactant can be added in amounts ranging from about 0.5 to about 15 wt %,
preferably about 1 to about 5 wt % of the film. Other suitable surfactants
include pluronic acid, sodium lauryl sulfate, and the like.
Preferred stabilizing agents include xanthan gum, locust bean gum and
carrageenan, in amounts ranging from about 0 to about 10 wt %, preferably
about 0.1 to about 2 wt % of the film. Other suitable stabilizing agents
include guar gum and the like.
Preferred emulsifying agents include triethanolamine stearate, quaternary
ammonium compounds, acacia, gelatin, lecithin, bentonite, veegum, and the
like, in amounts ranging from about 0 to about 5 wt %, preferably about 0.01
to about 0.7 wt % of the film.
Preferred thickening agents include methylcellulose, carboxyl
methylcellulose, and the like, in amounts ranging from about 0 to about 20
wt %, preferably about 0.01 to about 5 wt %.
Preferred binding agents include starch, in amounts ranging from about 0 to
about 10 wt %, preferably about 0.01 to about 2 wt % of the film.
Suitable sweeteners that can be included are those well known in the art,
including both natural and artificial sweeteners. Suitable sweeteners
include, e.g.: A. water-soluble sweetening agents such as monosaccharides,
disaccharides and polysaccharides such as xylose, ribose, glucose
(dextrose), mannose, galactose, fructose (levulose), sucrose (sugar),
maltose, invert sugar (a mixture of fructose and glucose derived from
sucrose), partially hydrolyzed starch, corn syrup solids, dihydrochalcones,
monellin, steviosides, and glycyrrhizin; B. water-soluble artificial
sweeteners such as the soluble saccharin salts, i.e., sodium or calcium
saccharin salts, cyclamate salts, the sodium, ammonium or calcium salt of
3,4-dihydro-6-methyl-1,2,3-oxathiazine-4-one-2, 2-dioxide, the potassium
salt of 3,4-dihydro-6-methyl-1,2,3-oxathiazine-4-one-2,2-dioxide (acesulfame-K),
the free acid form of saccharin, and the like; C. dipeptide based
sweeteners, such as L-aspartic acid derived sweeteners, such as L-aspartyl-L-phenylalanine
methyl ester (aspartame) and materials described in U.S. Pat. No. 3,492,131,
L-alpha-aspartyl-N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alaninamide hydrate,
methyl esters of L-aspartyl-L-phenylglycerin and
L-aspartyl-L-2,5,dihydrophenyl-glycine,
L-aspartyl-2,5-dihydro-L-phenylalanine, L-aspartyl-L-(1-cyclohexyen)-alanine,
and the like; D. water-soluble sweeteners derived from naturally occurring
water-soluble sweeteners, such as a chlorinated derivative of ordinary sugar
(sucrose), known, for example, under the product description of sucralose;
and E. protein based sweeteners such as thaumatoccous danielli (Thaumatin I
and II).
In general, an effective amount of auxiliary sweetener is utilized to
provide the level of sweetness desired for a particular composition, and
this amount will vary with the sweetener selected. This amount will normally
be 0.01% to about 10% by weight of the composition when using an easily
extractable sweetener. The water-soluble sweeteners described in category A
above, are usually used in amounts of about 0.01 to about 10 wt %, and
preferably in amounts of about 2 to about 5 wt %. Some of the sweeteners in
category A (e.g., glycyrrhizin) can be used in amounts set forth for
categories B-E below due to the sweeteners' known sweetening ability. In
contrast, the sweeteners described in categories B-E are generally used in
amounts of about 0.01 to about 10 wt %, with about 2 to about 8 wt % being
preferred and about 3 to about 6 wt % being most preferred. These amounts
may be used to achieve a desired level of sweetness independent from the
flavor level achieved from any optional flavor oils used. Of course,
sweeteners need not be added to films intended for non-oral administration.
The flavorings that can be used include those known to the skilled artisan,
such as natural and artificial flavors. These flavorings may be chosen from
synthetic flavor oils and flavoring aromatics, and/or oils, oleo resins and
extracts derived from plants, leaves, flowers, fruits and so forth, and
combinations thereof. Representative flavor oils include: spearmint oil,
cinnamon oil, peppermint oil, clove oil, bay oil, thyme oil, cedar leaf oil,
oil of nutmeg, oil of sage, and oil of bitter almonds. Also useful are
artificial, natural or synthetic fruit flavors such as vanilla, chocolate,
coffee, cocoa and citrus oil, including lemon, orange, grape, lime and
grapefruit and fruit essences including apple, pear, peach, strawberry,
raspberry, cherry, plum, pineapple, apricot and so forth. These flavorings
can be used individually or in admixture. Commonly used flavors include
mints such as peppermint, artificial vanilla, cinnamon derivatives, and
various fruit flavors, whether employed individually or in admixture.
Flavorings such as aldehydes and esters including cinnamyl acetate,
cinnamaldehyde, citral, diethylacetal, dihydrocarvyl acetate, eugenyl
formate, p-methylanisole, and so forth may also be used. Generally, any
flavoring or food additive, such as those described in Chemicals Used in
Food Processing, publication 1274 by the National Academy of Sciences, pages
63-258, may be used. Further examples of aldehyde flavorings include, but
are not limited to acetaldehyde (apple); benzaldehyde (cherry, almond);
cinnamic aldehyde (cinnamon); citral, i.e., alpha citral (lemon, lime);
neral, i.e. beta citral (lemon, lime); decanal (orange, lemon); ethyl
vanillin (vanilla, cream); heliotropine, i.e., piperonal (vanilla, cream);
vanillin (vanilla, cream); alpha-amyl cinnamaldehyde (spicy fruity flavors);
butyraldehyde (butter, cheese); valeraldehyde (butter, cheese); citronellal
(modifies, many types); decanal (citrus fruits); aldehyde C-8 (citrus
fruits); aldehyde C-9 (citrus fruits); aldehyde C-12 (citrus fruits);
2-ethyl butyraldehyde (berry fruits); hexenal, i.e. trans-2 (berry fruits);
tolyl aldehyde (cherry, almond); veratraldehyde (vanilla);
2,6-dimethyl-5-heptenal, i.e. melonal (melon); 2-6-dimethyloctanal (green
fruit); and 2-dodecenal (citrus, mandarin); cherry; grape; mixtures thereof;
and the like.
The amount of flavoring employed is normally a matter of preference subject
to such factors as flavor type, individual flavor, and strength desired.
Thus, the amount may be varied in order to obtain the result desired in the
final product. Such variations are within the capabilities of those skilled
in the art without the need for undue experimentation. In general, amounts
of about 0.1 to about 30 wt % are useable with amounts of about 2 to about
25 wt % being preferred and amounts from about 8 to about 10 wt % are more
preferred.
The compositions of this invention can also contain coloring agents or
colorants. The coloring agents are used in amounts effective to produce the
desired color. The coloring agents useful in the present invention, include
pigments such as titanium dioxide, which may be incorporated in amounts of
up to about 5 wt %, and preferably less than about 1 wt %. Colorants can
also include natural food colors and dyes suitable for food, drug and
cosmetic applications. These colorants are known as FD&C dyes and lakes. The
materials acceptable for the foregoing spectrum of use are preferably
water-soluble, and include FD&C Blue No. 2, which is the disodium salt of
5,5-indigotindisulfonic acid. Similarly, the dye known as Green No. 3
comprises a triphenylmethane dye and is the monosodium salt of
4-[4-N-ethyl-p-sulfobenzylamino) diphenyl-methylene]-[1-N-ethyl-N-p-sulfonium
benzyl)-2,5-cyclo-hexadienimine]. A full recitation of all FD&C and D&C dyes
and their corresponding chemical structures may be found in the Kirk-Othmer
Encyclopedia of Chemical Technology, Volume 5, Pages 857-884, which text is
accordingly incorporated herein by reference.
Antimicrobial Efficacy of Oral Care Films
The preferred embodiment of the oral care film composition according to the
present invention contains the essential oils used in Listerine.RTM.
mouthwash to provide antimicrobial efficacy. The films are shaped and sized
to be placed in the oral cavity. The film adheres to a surface in the mouth,
usually the roof of the mouth or the tongue, and quickly dissolves. The
amount of essential oils in one individual film that is a preferred size for
placing in the mouth is significantly lower than that in the recommended
amount, 20 ml, of Listerine.RTM. mouthwash.
In a preferred formula according to the present invention, the amount of
thymol and eucalyptol in the film is about 70 times less than in the
mouthwash. The amount of methyl salicylate in the film is about 46 times
less than in the mouthwash. The amount of menthol in the film is about 2.8
times less than in the mouthwash. These figures are based on comparing a 20
ml dose of liquid mouthwash with a 0.0358 gram film.
The inventors have unexpectedly found that the film provides sustained
antimicrobial efficacy at these low amounts of oils. The inventors believe
that the efficacy of the essential oils is enhanced by the creation of a
layer of pullulan in the oral cavity that holds the essential oils. This is
unexpected because pullulan is water-soluble and the film dissolves very
quickly.
The extended antimicrobial activity is shown in the following experiments.
The purpose of these experiments was to determine the antibacterial efficacy
of an application of a breath film on tongue malodor microorganisms thirty,
sixty or ninety minutes after use. The thirty minute study also tested the
efficacy of using two films. Subjects' baseline oral malodor microbial
recoverable counts were determined by plating the microorganisms recovered
from a tongue swab on a selective agar medium. The test product was
dispensed and subjects dissolved one or two breath films on their tongue.
Subjects remained on the premises and returned for a second tongue swab
thirty, sixty or ninety minutes after placement of the test product on their
tongue. After a forty-eight hour washout period, subjects returned for a no
treatment control.
The thirty minute single film use group showed a reduction in mean log
malodor microbial counts compared to the control group. The data was
borderline statistically significant (p=0.052). The difference between the
one film group and the no treatment control group represented a 42.7%
reduction in malodor microbial colony counts.
Statistically significant malodor microbial reduction was also observed with
the two film use group. A 79.6% reduction in malodor microbial colony counts
was obtained (p<0.001).
Statistically significant malodor microbial reduction was observed sixty
minutes after use of a single breath film. A 69.8% reduction in malodor
microbial colony counts was obtained (p=0.002).
Significant malodor reduction was also observed ninety minutes after use of
a single breath film. A 69.1% reduction in malodor microbial colony counts
was obtained (p=0.006).
The data from these studies support the following conclusions: (1) Pullulan
polymer-based breath film containing essential oils is an effective
antibacterial composition against oral malodor causing bacteria and (2)
significant in vivo bacterial reductions were achieved at thirty, sixty and
ninety minutes post use.
Claim 1 of 16 Claims
1. A consumable film adapted to rapidly
dissolve in the mouth of a consumer, wherein said film comprises a single
layer including pullulan, from about 0.1% to about 2 wt % of a stabilizing
agent comprising a mixture of xanthan gum, locust bean gum and carrageenan
and at least one pharmaceutical agent, wherein said pharmaceutical agent
is selected from the group consisting of non-steroidal anti-inflammatory
agents, antitussives, decongestants, anti-histamines, expectorants, anti-diarrheals,
H2-antagonists, proton pump inhibitors, central nervous system agents,
analgesics and mixtures thereof.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|